Galderma to buy US firm ZO Skin Health for $1.5 billion

FILE PHOTO: A logo of skin care company Galderma is pictured on the company's offices in Lausanne, Switzerland, March 13, 2024.

FILE PHOTO: A logo of skin care company Galderma is pictured on the company's offices in Lausanne, Switzerland, March 13, 2024. (REUTERS/Denis Balibouse/File Photo)


1 photo
Save Story

Estimated read time: Less than a minute

ZURICH, Oct 14 — Swiss skincare firm Galderma said ​on Wednesday it had agreed to acquire US-based company ZO Skin Health ‌for an enterprise value of $1.5 billion, confirming a report ⁠published by Reuters ​earlier in the ⁠day.

• The acquisition brings together two ‌complementary, science-backed skincare ‌brands, ZO Skin Health and Galderma's ⁠Alastin

• Galderma said ⁠the deal would expand its dermatological skincare offering in fast-growing, physician-dispensed skincare and support ZO Skin Health's next phase of growth.

• The transaction is expected ‌to close in the ​fourth quarter of 2026 or early 2027, subject to regulatory approvals.

• The Swiss company said the acquisition of 100% of ZO Skin Health is expected to be neutral to core earnings per ​share in the first full year ‌after the ‌transaction ⁠closes.

• Irvine, California-based ZO Skin Health has operated in professional skincare for more than 20 years.

• ZO Skin Health logged ‌net sales of around $330 ​million in the ‌twelve months leading ⁠up ​to June 2026.

(Writing by Dave GrahamEditing by Linda ​Pasquini)

Photos

Most recent Lifestyle stories

Related topics

KSL.com Beyond Business
KSL.com Beyond Series

KSL Weather Forecast

KSL Weather Forecast
Play button